Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy - Scorecard - MDSpire

Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy

  • By

  • Da Huang

  • Yuxuan Guo

  • Mingfen Chen

  • Guoqun Chen

  • Guangchun He

  • Chanjuan Zheng

  • Shujun Fu

  • Jie Wang

  • Yian Wang

  • Xiyun Deng

  • January 30, 2026

  • 0 min

Share

Clinical Scorecard: Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy

At a Glance

CategoryDetail
Condition
Key MechanismsC4orf19 expression correlates with immune function and treatment sensitivity, as evidenced by recent studies.
Target Population
Care Setting

Key Highlights

  • 5_year_survival_rate

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • U
      • s
      • e
      • o
      • f
      • C
      • 4
      • o
      • r
      • f
      • 1
      • 9
      • e
      • x
      • p
      • r
      • e
      • s
      • s
      • i
      • o
      • n
      • l
      • e
      • v
      • e
      • l
      • s
      • t
      • o
      • p
      • r
      • e
      • d
      • i
      • c
      • t
      • t
      • r
      • e
      • a
      • t
      • m
      • e
      • n
      • t
      • o
      • u
      • t
      • c
      • o
      • m
      • e
      • s
      • ,
      • i
      • n
      • c
      • l
      • u
      • d
      • i
      • n
      • g
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • m
      • e
      • t
      • r
      • i
      • c
      • s
      • s
      • u
      • c
      • h
      • a
      • s
      • e
      • x
      • p
      • r
      • e
      • s
      • s
      • i
      • o
      • n
      • t
      • h
      • r
      • e
      • s
      • h
      • o
      • l
      • d
      • s
      • .

      Risks

        Patient & Prescribing Data

        Treatment-naive HNSCC patients.

        C4orf19 expression may guide chemotherapy and immunotherapy decisions.

        Clinical Best Practices

        • details

        References

        Original Source(s)

        Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy

        • by Da Huang, Yuxuan Guo, Mingfen Chen, Guoqun Chen, Guangchun He, Chanjuan Zheng, Shujun Fu, Jie Wang, Yian Wang, Xiyun Deng

        • January 30, 2026

        Related Content

        Anti-PD-1 monoclonal antibody combined with chemotherapy for porocarcinoma: a case report and literature review

        Perioperative immunotherapy in resectable HNSCC: biological rationale to practical multidisciplinary implementation

        Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study